Cellebrite pursues corporate reorganization to redomicile parent company in US
CLBT•Corporate reorganization to create a new U.S. parent
Cellebrite authorized a corporate reorganization to create a new U.S. corporation as the ultimate parent.
The transaction requires shareholder approvals plus regulatory clearances.
Redomiciling aims to support growth in its largest market, the U.S., while broadening access to government customers overseas.
The move is intended to expand investor appeal through potential inclusion in key indices.
Completion is targeted for the first half of 2027.
